Kezar Life Sciences' Zetomipzomib IND For Lupus Nephritis Placed On Clinical Hold By FDA; Stock Down

RTTNewsOct 4 17:31 ET

Express News | Kezar Life Sciences: Action Follows Co's Communication to FDA That Co Was Suspending Enrollment, Dosing in Phase 2B Palizade Clinical Trial

ReutersOct 4 17:03 ET

Kezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus Nephritis

BusinesswireOct 4 17:00 ET

Express News | Kezar Life Sciences Announces Clinical Hold of Zetomipzomib Ind for Treatment of Lupus Nephritis

ReutersOct 4 17:00 ET

12 Health Care Stocks Moving In Friday's Intraday Session

BenzingaOct 4 12:32 ET

H.C. Wainwright Downgrades Kezar Life Sciences(KZR.US) to Hold Rating

Moomoo NewsOct 2 06:37 ET · Ratings